ASG-5ME

ASG-5ME · Seagen Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASG-5ME, covering 2013-06-07 to 2013-08-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma [Phase 1]